This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huang, Y. Articles by Kelly, T. Search for Related Content PubMed PubMed Citation Articles by Huang, Y. Articles by Kelly, T.

Seprase Promotes Rapid Tumor Growth and Increased Microvessel Density in a Mouse Model of Human Breast Cancer

Department of Pathology, Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Seprase is a cell surface serine protease that is expressed to high levels by invading human breast carcinoma cells. To investigate the role of seprase in breast cancer, MDA MB-231 human mammary adenocarcinoma cells were engineered to express active seprase to high levels. All cells grow rapidly in cell culture. But differences are discovered when the cells are tested for tumorigenicity, growth, and microvessel density by implantation into the mammary fat pads of female severe combined immunodeficient mice. Control transfectants that do not express seprase grow slowly whereas cells that express seprase to high levels form fast-growing tumors that are highly vascular. Microvessel density is elevated in tumors of two different lines of seprase transfectants to 146 ± 67.4 and 144 ± 33.42 vessels/mm² as compared with 50.5 ± 12.9 vessels/mm² for tumors of control-transfected cells that do not express seprase. Seprase-expressing cells are better able to attract blood vessels and exhibit rapid tumor growth.

This article has been cited by other articles:

				L. R. Henry, H.-O. Lee, J. S. Lee, A. Klein-Szanto, P. Watts, E. A. Ross, W.-T. Chen, and J. D. Cheng Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer Clin. Cancer Res., March 15, 2007; 13(6): 1736 - 1741. [Abstract] [Full Text] [PDF]

				D. Chen, A. Kennedy, J.-Y. Wang, W. Zeng, Q. Zhao, M. Pearl, M. Zhang, Z. Suo, J. M. Nesland, Y. Qiao, et al. Activation of EDTA-Resistant Gelatinases in Malignant Human Tumors. Cancer Res., October 15, 2006; 66(20): 9977 - 9985. [Abstract] [Full Text] [PDF]

				G. Ghersi, Q. Zhao, M. Salamone, Y. Yeh, S. Zucker, and W.-T. Chen The Protease Complex Consisting of Dipeptidyl Peptidase IV and Seprase Plays a Role in the Migration and Invasion of Human Endothelial Cells in Collagenous Matrices. Cancer Res., May 1, 2006; 66(9): 4652 - 4661. [Abstract] [Full Text] [PDF]

				V. W.M. van Hinsbergh, M. A. Engelse, and P. H.A. Quax Pericellular Proteases in Angiogenesis and Vasculogenesis Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 716 - 728. [Abstract] [Full Text] [PDF]

				C. Y. Edosada, C. Quan, C. Wiesmann, T. Tran, D. Sutherlin, M. Reynolds, J. M. Elliott, H. Raab, W. Fairbrother, and B. B. Wolf Selective Inhibition of Fibroblast Activation Protein Protease Based on Dipeptide Substrate Specificity J. Biol. Chem., March 17, 2006; 281(11): 7437 - 7444. [Abstract] [Full Text] [PDF]

				K. N. Lee, K. W. Jackson, V. J. Christiansen, C. S. Lee, J.-G. Chun, and P. A. McKee Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein Blood, February 15, 2006; 107(4): 1397 - 1404. [Abstract] [Full Text] [PDF]

				T. Kelly, L. J. Suva, Y. Huang, V. MacLeod, H.-Q. Miao, R. C. Walker, and R. D. Sanderson Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases Cancer Res., July 1, 2005; 65(13): 5778 - 5784. [Abstract] [Full Text] [PDF]

				J. D. Cheng, M. Valianou, A. A. Canutescu, E. K. Jaffe, H.-O. Lee, H. Wang, J. H. Lai, W. W. Bachovchin, and L. M. Weiner Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth Mol. Cancer Ther., March 1, 2005; 4(3): 351 - 360. [Abstract] [Full Text] [PDF]